ClearAlpha Technologies’s MetLife MET Stock Holding History

ClearAlpha Technologies’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,131	Closed	-$292K	–	100
2026 Q1	$292K	Sell	4,131 -2,608	-39%	-$195K	0.6%	56
2025 Q4	$532K	Buy	+6,739	New	+$533K	1.52%	20

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearAlpha Technologies's MET Position: Q2 2026 in Review

ClearAlpha Technologies sold out of MetLife (MET) in Q2 2026, closing a stake of 4,131 shares — an estimated $292K sold.

ClearAlpha Technologies first reported a position in MET in Q4 2025 and held it in 2 quarters. The position peaked at $532K in Q4 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

ClearAlpha Technologies reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
ClearAlpha Technologies sold 4,131 MetLife shares in Q2 2026, an estimated $292K.
ClearAlpha Technologies first reported a position in MetLife in Q4 2025 and held it in 2 quarters.
ClearAlpha Technologies's MetLife position peaked at $532K in Q4 2025.
1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on ClearAlpha Technologies's 13F filing for Q2 2026, filed 14 Aug 2026.